Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Inhaled insulin feasible and acceptable in patients with diabetes

May 27, 2005

A drospirenone/ethinylestradiol combination shows promise in PMDD

May 27, 2005

Phase II data on the effects of 4-OHT in cyclic mastalgia

May 27, 2005

Tanaproget shows efficacy as a novel contraceptive in healthy women

May 27, 2005

Update on paricalcitol in the treatment of SHPT

May 27, 2005

NOX-B11: A novel ghrelin antagonist for obesity

May 27, 2005

Recent patents report novel agents for lipoprotein disorders

May 26, 2005

New agents for treating obesity disclosed by Bristol-Myers Squibb

May 26, 2005

New treatments for type 2 diabetes reported

May 25, 2005

Investigation of pasireotide progresses

May 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...